Phototherapy with Narrow-Band Ultraviolet B in Adult Psoriasis: A Study in Clinical Practice

M. Fernández-Guarino, S. AboínGonzález, Á. González-Cantero, C. Arsuaga, P. Lázaro
{"title":"Phototherapy with Narrow-Band Ultraviolet B in Adult Psoriasis: A Study in Clinical Practice","authors":"M. Fernández-Guarino, S. AboínGonzález, Á. González-Cantero, C. Arsuaga, P. Lázaro","doi":"10.35248/2155-9554.20.11.521","DOIUrl":null,"url":null,"abstract":"Introduction: Large prospective studies evaluating efficacy of narrow band ultraviolet B (NB-UVB) in psoriasis in terms of PASI75 and PASI90 are scarce in the literature. Material and methods: A prospective, open and observational study was conducted. Patients treated with narrow band ultraviolet B (NB-UVB) for psoriasis was included. Treatment target was a reduction of 90% from basal PASI (PASI90), but if patients did not achieve this response after 20 sessions, treatment was continued until PASI75 clearance was achieved. Patients were followed up and relapses were retreated with the same PASI at the first time. Relation between PASI before treatment and total doses needed to achieve PASI75 or PASI90 was studied. Results: Among the 242 patients that received NB-UVB for psoriasis, 102 had guttate psoriasis (GP) and 122 had plaque psoriasis (PP). PASI90 was achieved in 89.1% of patients with GP and 64,8% of patients with PP. Response was significantly better (p<0.05) in GP patients. Retreated patients affected of PP needed the same doses as the first treatment received (p>0.005). Patients with higher PASI need more doses to clear up. Conclusion: Phototherapy with NB-UVB is significantly more effective in patients with GP than patients with PP. Patients retreated seems to need the same doses. Initial PASI can predict the total doses needed to achieve PASI75 or PASI90.","PeriodicalId":15448,"journal":{"name":"Journal of clinical & experimental dermatology research","volume":"399 1","pages":"1-7"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of clinical & experimental dermatology research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2155-9554.20.11.521","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Introduction: Large prospective studies evaluating efficacy of narrow band ultraviolet B (NB-UVB) in psoriasis in terms of PASI75 and PASI90 are scarce in the literature. Material and methods: A prospective, open and observational study was conducted. Patients treated with narrow band ultraviolet B (NB-UVB) for psoriasis was included. Treatment target was a reduction of 90% from basal PASI (PASI90), but if patients did not achieve this response after 20 sessions, treatment was continued until PASI75 clearance was achieved. Patients were followed up and relapses were retreated with the same PASI at the first time. Relation between PASI before treatment and total doses needed to achieve PASI75 or PASI90 was studied. Results: Among the 242 patients that received NB-UVB for psoriasis, 102 had guttate psoriasis (GP) and 122 had plaque psoriasis (PP). PASI90 was achieved in 89.1% of patients with GP and 64,8% of patients with PP. Response was significantly better (p<0.05) in GP patients. Retreated patients affected of PP needed the same doses as the first treatment received (p>0.005). Patients with higher PASI need more doses to clear up. Conclusion: Phototherapy with NB-UVB is significantly more effective in patients with GP than patients with PP. Patients retreated seems to need the same doses. Initial PASI can predict the total doses needed to achieve PASI75 or PASI90.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
窄带紫外线B光疗治疗成人银屑病的临床研究
文献中很少有以PASI75和PASI90评价窄带紫外线B (NB-UVB)治疗银屑病疗效的大型前瞻性研究。材料与方法:采用前瞻性、开放性、观察性研究。采用窄带紫外线B (NB-UVB)治疗银屑病患者。治疗目标是将基础PASI (PASI90)降低90%,但如果患者在20个疗程后仍未达到这一反应,则继续治疗直到PASI75清除。对患者进行随访,复发患者第一次采用相同的PASI治疗。研究治疗前PASI与达到PASI75或PASI90所需的总剂量之间的关系。结果:在242例接受NB-UVB治疗的银屑病患者中,102例为点滴状银屑病(GP), 122例为斑块状银屑病(PP)。89.1%的GP患者和64.8%的PP患者达到了PASI90,疗效明显更好(p0.005)。PASI较高的患者需要更多的剂量来清除。结论:NB-UVB光疗治疗GP患者的效果明显优于PP患者,治疗后患者似乎需要相同的剂量。初始PASI可以预测达到PASI75或PASI90所需的总剂量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Observed Causal Relationship Between Eczema and Inflammatory Bowel Diseases Transient Eosinophilic Nodulomatosis: A Report of Two Cases ORF Nodule Complicated by Erythema Multiforme: About 2 Cases Erythema Nodosum Leprosum and Thalidomide: How Effective? Autoimmune Diseases a Late Complication of Toxic Epidermal Necrolysis: A Case Report
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1